Furthermore, immunohistochemistry and Western blot analyses indicated that propranolol inhibited EMT in vivo, as evidenced by the upregulation of E-cadherin and downregulation of vimentin in tumor tissue (implantation site) in the propranolol group compared to the control group (Fig. 1C–F). Here, CDH1 is linked to neoplasm.